Electrolyte Imbalance Analysis at Intensive Care Unit Admission : Retrospective Study

Electrolyte Imbalance Clinical Trial

Official title:

Electrolyte Imbalance Analysis at Icu Admission : Retrospective Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05052463
• Other study ID #: erbil elektrolit
• Status: Completed
• Start date: December 10, 2019
• Est. completion date: August 15, 2021

Study information

• Verified date: September 2021
• Source: Kecioren Education and Training Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The type and severity of electrolyte imbalance in patients admitted to the intensive care unit were analyzed.It was evaluated whether these results had an effect on mortality, length of hospital stay, APACHE II scores and ventilator days

Recruitment information / eligibility

• Status: Completed
• Enrollment: 824
• Est. completion date: August 15, 2021
• Est. primary completion date: April 5, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria: all of the icu patients - Exclusion Criteria: -

Related Conditions & MeSH terms

• Electrolyte Imbalance

Intervention

Other:
• electrolyte imbalance analysis
in this retrospective study we aimed to evaluate the relationship between the icu prognosis and the electrolyte imbalance

Locations

Country	Name	City	State
Turkey	Ankara Kecioren Training and Research Hospital	Ankara	Çankaya

Sponsors (1)

Lead Sponsor	Collaborator
Kecioren Education and Training Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The analysis the electrolyte imbalance in ICU and the relationship between the icu prognosis.	Natremia (Hypo: <136 mmol/L, Normo: 136-145 mmol/L, Hyper: >145 mmol/L) Kalemia (Hypo: <3.5 mmol/L, Normo: 3.5-5.5 mmol/L, Hyper: >5.5 mmol/L) Calcemia (Hypo: <8.8 mg/dL, Normo: 8.8-10.6 mg/dL, Hyper: >10.6 mg/dL) Magnesemia (Hypo: <1.9 mg/dL, Normo: 1.9-2.5 mg/dL, Hyper: >2.5 mg/dL) Phosphatemia (Hypo: <2.5 mg/dL, Normo: 2.5-4.5 mg/dL, Hyper: >4.5 mg/dL); The number of patients in all types of electrolyte imbalance will be determined. The effect of the type of electrolyte imbalance on mortality, APACHE-II score and length of invasive ventilation and hospital stay will be evaluated.	2 years